Browsing Category
Pharma Industry News
4754 posts
Business-News-Today.com section for global pharma industry news, Indian pharma sector latest news, pharma sector news today, pharmaceuticals industry news.
Liquidia Corporation shares soar 13% following dual financing announcement
Liquidia Corporation experienced a dramatic surge in its stock price, climbing 13% to $10.02, following the announcement of…
September 11, 2024
Breakthrough in breast cancer treatment? BriaCell Therapeutics shares soar 150%!
BriaCell Therapeutics Corp., a clinical-stage biotechnology company, saw its shares surge by more than 150% to $1.55 following…
September 11, 2024
Terns Pharmaceuticals faces market pressure following stock offering announcement
Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing small-molecule product candidates for serious diseases such as oncology and…
September 11, 2024
Novo Nordisk stock climbs 1.52% as obesity drug Liraglutide shows promise in young kids
Novo Nordisk A/S shares climbed by 1.52% today to 888.60 DKK, following the release of promising new data…
September 11, 2024
AstraZeneca’s breakthrough in lung cancer treatment: Datopotamab deruxtecan achieves promising survival rates
AstraZeneca’s datopotamab deruxtecan (Dato-DXd), a cutting-edge TROP2-directed antibody-drug conjugate, has demonstrated encouraging overall survival results in the TROPION-Lung01…
September 9, 2024
Xencor stock skyrockets 26% overnight after breakthrough in cancer research
Xencor, Inc., a clinical-stage biopharmaceutical company specializing in engineered antibodies for cancer treatment, saw its stock rise by…
September 9, 2024
NImmune Biopharma collaborates with BioTherapeutics on next-gen precision medicines
NImmune Biopharma has entered into a strategic partnership with BioTherapeutics, a clinical-stage biotech company based in Virginia, to…
September 8, 2024
Primary IgA nephropathy : FDA grants full approval to Travere Therapeutics’ Filspari
In a groundbreaking move, the US Food and Drug Administration (FDA) has granted full approval to Travere Therapeutics’…
September 8, 2024
Granules India faces six observations after US FDA inspection at Gagillapur facility in Hyderabad
Granules India Limited has recently completed a US Food and Drug Administration (US FDA) inspection at its Gagillapur…
September 7, 2024
Instil Bio makes shock move: Shuts down UK operations and slashes jobs
Instil Bio, Inc., a clinical-stage biopharmaceutical company headquartered in Dallas, Texas, is undergoing a significant restructuring that includes…
September 7, 2024